Advanced healthcare consulting integrating clinical expertise, financial rigor, innovation strategy, and organizational intelligence — built for organizations that demand more than a generic advisory firm.
Most consulting firms specialize in one domain. NEG Plus PLLC integrates them all — bridging clinical credibility, financial rigor, strategic precision, organizational intelligence, and policy fluency.
Board-certified OBGYN with deep women's health and oncology expertise
Advanced modeling, valuation, capital structure, and cost analysis
Organizational design, relational coordination, performance optimization
Proven frameworks from McKinsey, BCG, and leading business schools
Healthcare economics, payer strategy, and regulatory navigation
Comprehensive expertise across the full healthcare value chain — from bench to boardroom.
End-to-end advisory across every phase of pharmaceutical and biologic development — integrating regulatory strategy, clinical expertise, and business rigor from first concept through full lifecycle management.
Physician-led advisory integrating deep regulatory knowledge, clinical trial expertise, and commercial strategy across the full IND-to-NDA/BLA continuum — and beyond to LOE defense and indication expansion.
Comprehensive advisory across the full medical device development lifecycle — from concept and design controls through FDA clearance or approval, commercial launch, and post-market surveillance — spanning technical rigor and commercial strategy.
Physician-led advisory on design controls, regulatory pathway strategy, QMS architecture, and go-to-market execution — integrating FDA regulatory expertise with commercial and business strategy across capital equipment, consumables, SaMD, combination products, and diagnostics.
Drug-device combination products, companion diagnostics, drug delivery systems, and Software as a Medical Device (SaMD) require integrated expertise across both tracks. NEG Plus PLLC advises on 21 CFR Part 3 combination product classification, FDA Office of Combination Products (OCP) interactions, and the unified regulatory, technical, and commercial strategy these programs demand.
Proven analytical frameworks from leading consulting firms and business schools — applied with healthcare-specific judgment and clinical context.
Organizations at the forefront of healthcare innovation, transformation, and value creation.
Early-stage to commercial companies developing breakthrough therapeutics, devices, and diagnostics — with women's health expertise at the table.
Institutions integrating research, education, and clinical excellence — navigating growth, governance, and strategic positioning.
Organizations undergoing transformation, service line expansion, or repositioning in an increasingly competitive market.
Investment firms building and evaluating healthcare portfolios — with clinical credibility at the diligence table.
Growth-stage companies commercializing digital health, diagnostics, therapeutics, or health services — accelerating market entry.
C-suites, physician leaders, and boards navigating high-stakes strategic decisions and organizational transformation.
Engagements designed around your organization's specific needs — from rapid-cycle diagnostics to long-term advisory relationships.
Rapid assessment of positioning, competitive landscape, and strategic opportunities. Delivered in 2–4 weeks.
Comprehensive analysis of financial performance, cost structure, capital optimization, and investment modeling.
Ongoing strategic counsel for executive leadership and governance teams on a retainer or project basis.
End-to-end commercialization planning from concept through regulatory clearance and market launch.
Intensive leadership development for physician executives navigating high-stakes decisions and organizational influence.
System-wide organizational redesign for health systems navigating strategic pivots, mergers, or restructuring.
Capital allocation, asset prioritization, and risk-adjusted pipeline optimization for biotech and PE portfolios.
Clinical, financial, and strategic expert analysis for medico-legal matters in women's health and healthcare management.
Keynotes, grand rounds, faculty development, and executive education on strategy, innovation, and physician leadership.
Dr. Jimmy Belotte is a board-certified obstetrician-gynecologist and the founder and managing principal of New England Gynecology Plus PLLC. He combines deep clinical expertise in women's health, gynecologic oncology, and minimally invasive surgery with advanced business training — including an MBA with concentrations in healthcare management, corporate finance, and strategic management.
Dr. Belotte's consulting practice sits at the intersection of medicine, capital markets, and organizational systems — serving health systems, biotech companies, academic medical centers, private equity investors, and executive leadership teams. He brings a rare dual fluency: the clinical judgment of a practicing physician and the analytical sophistication of a trained strategist and financial modeler.
His advisory work encompasses clinical strategy, financial valuation, innovation and regulatory advisory, organizational transformation, and board-level counsel — with a particular emphasis on women's health, oncology, and the intersection of technology and healthcare delivery.
Dr. Jimmy Belotte is an experienced speaker at the intersection of clinical medicine, healthcare strategy, and business leadership — delivering programs that challenge thinking, build capacity, and inspire action across academic medicine and industry.
Healthcare conferences, medical society meetings, and industry summits — 30 to 60 minutes
Academic medical centers, residency programs, and department seminars on clinical and strategic topics
C-suite workshops, leadership development programs, and MBA/MPH guest faculty sessions
Health policy forums, biotech investor panels, and innovation symposia — as panelist or moderator
Strategic briefings for boards of directors, governance committees, and executive leadership teams
Medical school curricula, resident didactics, and continuing medical education (CME) programs
Dr. Belotte tailors every program to the audience — blending evidence-based clinical insights with rigorous strategic analysis. Engagements are available in-person, hybrid, or virtually. Contact us to discuss availability, honoraria, and program customization.
Let's discuss how NEG Plus PLLC's consulting practice can accelerate your organization's most critical strategic objectives.